Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
285.58
256.99
218.25
244.40
207.47
197.99
210.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
285.58
256.99
218.25
244.40
207.47
197.99
210.42
Raw Material Cost
94.64
111.26
86.22
95.37
93.41
76.61
97.41
Purchase of Finished goods
15.10
18.21
20.20
2.26
20.57
13.53
19.03
(Increase) / Decrease In Stocks
4.71
-16.01
-4.76
20.42
-22.10
9.29
-2.25
Employee Cost
43.05
36.14
35.94
33.35
31.00
28.24
29.76
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
51.68
62.95
45.86
49.52
43.25
49.23
36.67
Total Expenditure (Excl Depreciation)
209.17
212.55
183.46
200.92
166.14
176.90
180.63
Operating Profit (PBDIT) excl Other Income
76.41
44.44
34.79
43.48
41.33
21.09
29.79
Other Income
9.60
11.16
18.46
8.46
35.45
12.07
15.27
Operating Profit (PBDIT)
86.01
55.60
53.25
51.94
76.78
33.16
45.06
Interest
0.58
2.01
1.49
3.04
5.47
1.68
1.08
Exceptional Items
0.00
0.03
-2.51
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
85.43
53.62
49.25
48.90
71.31
31.48
43.98
Depreciation
9.94
8.67
8.35
8.26
8.20
8.04
7.55
Profit Before Tax
75.48
44.95
40.90
40.63
63.11
23.44
36.42
Tax
24.11
7.95
16.12
12.04
18.75
6.79
10.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.37
37.00
24.78
28.59
44.36
16.65
25.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.37
37.00
24.78
28.59
44.36
16.65
25.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.27
1.42
1.51
1.34
1.32
1.11
2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.10
35.58
23.27
27.25
43.04
15.54
23.80
Equity Capital
10.61
10.58
10.58
10.56
10.55
10.54
10.54
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.72
3.36
2.2
2.58
4.08
1.47
2.26
Diluted Earnings per share
4.65
3.28
2.14
2.54
4.04
1.46
2.27
Operating Profit Margin (Excl OI)
26.76%
17.29%
15.94%
17.79%
19.92%
10.65%
14.16%
Gross Profit Margin
29.91%
20.86%
22.57%
20.01%
34.37%
15.9%
20.9%
PAT Margin
17.99%
14.4%
11.35%
11.7%
21.38%
8.41%
12.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 37.65% vs 12.98% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 16.40% vs 107.92% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 84.88% vs 20.39% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -89.40% vs 257.52% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Bliss GVS Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
285.58
535.80
-250.22
-46.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
285.58
535.80
-250.22
-46.70%
Raw Material Cost
94.64
251.87
-157.23
-62.43%
Purchase of Finished goods
15.10
27.42
-12.32
-44.93%
(Increase) / Decrease In Stocks
4.71
-42.69
47.40
111.03%
Employee Cost
43.05
50.32
-7.27
-14.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
51.68
112.78
-61.10
-54.18%
Total Expenditure (Excl Depreciation)
209.17
399.69
-190.52
-47.67%
Operating Profit (PBDIT) excl Other Income
76.41
136.11
-59.70
-43.86%
Other Income
9.60
0.45
9.15
2,033.33%
Operating Profit (PBDIT)
86.01
136.56
-50.55
-37.02%
Interest
0.58
12.88
-12.30
-95.50%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
85.43
123.68
-38.25
-30.93%
Depreciation
9.94
30.03
-20.09
-66.90%
Profit Before Tax
75.48
101.06
-25.58
-25.31%
Tax
24.11
24.92
-0.81
-3.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
51.37
68.73
-17.36
-25.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
51.37
68.73
-17.36
-25.26%
Share in Profit of Associates
0.00
7.41
-7.41
-100.00%
Minority Interest
1.27
0.00
1.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.10
76.14
-26.04
-34.20%
Equity Capital
10.61
45.34
-34.73
-76.60%
Face Value
1.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.72
8.40
-3.68
-43.81%
Diluted Earnings per share
4.65
8.39
-3.74
-44.58%
Operating Profit Margin (Excl OI)
26.76%
25.40%
0.00
1.36%
Gross Profit Margin
29.91%
23.08%
0.00
6.83%
PAT Margin
17.99%
14.21%
0.00
3.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 285.58 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 11.12% vs 17.75% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 37.65% vs 12.98% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 50.10 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 40.81% vs 52.90% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 16.40% vs 107.92% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.41 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 71.94% vs 27.74% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 84.88% vs 20.39% in Jun 2025
Quarterly - Interest
Interest 0.58 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is -71.14% vs 34.90% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -89.40% vs 257.52% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.76%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
